Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion type Assertion NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_head.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion description "[The putative association between erbB-2 overexpression and favorable response to anthracyline-based therapy in breast cancer is controversial, and the mechanism unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_provenance.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion evidence source_evidence_literature NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_provenance.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion SIO_000772 11948114 NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_provenance.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion wasDerivedFrom befree-2016 NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_provenance.
- NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_assertion wasGeneratedBy ECO_0000203 NP351413.RAcb8YMbuLJ8Uy-gggejo1gW0scNbRmAmbhG7678nvbpE130_provenance.